Bristol Myers vs. Pfizer: Which High‑Yield Dividend Stock Wins Now?

Both are working hard to get around patent cliffs. One of them seems to have made more progress on that front.
Open original source
Both are working hard to get around patent cliffs. One of them seems to have made more progress on that front.
Open original source